youtube_live
Penghasilan pada Q3 2026 • dirilis • EPS melampaui perkiraan +39,80% • Pendapatan melampaui perkiraan +1,14%
Lihat hasilchevron_right
TMCI:NASDAQ
Treace Medical Concepts, Inc
US$4,03
arrow_downward
-3,59%(-0,15) 1 HR
US$4,11
arrow_upward
+1,99% (+0,080)bedtimeSetelah jam perdagangan normal
Tutup: 6 Nov, 16.00.00 GMT-5 · USD
search
Semua simbol
| Simbol | Harga | Perubahan | Persentase Perubahan |
|---|
insights_autoMembuat insight teratas untuk TMCI...
Pembukaan
US$3,95
Tinggi
US$4,23
Rendah
US$3,42
Kapitalisasi pasar
262,09 jt
Volume rata-rata
217,45 rb
Volume
596,72 rb
Harga tinggi dalam 52 minggu terakhir
US$5,25
Harga rendah dalam 52 minggu terakhir
US$1,17
EPS
-US$0,93
Beta
1,59
Saham beredar
65,04 jt
Jumlah karyawan
450
Pembukaan
US$3,95
Tinggi
US$4,23
Rendah
US$3,42
Kapitalisasi pasar
262,09 jt
Volume rata-rata
217,45 rb
Volume
596,72 rb
Harga tinggi dalam 52 minggu terakhir
US$5,25
Harga rendah dalam 52 minggu terakhir
US$1,17
EPS
-US$0,93
Beta
1,59
Saham beredar
65,04 jt
Jumlah karyawan
450
Artikel berita
Dari sumber web dan partner berita
Yahoo Finance
·
16 jam yang lalu
TMCI 10-Q & SEC Filings
GuruFocus
·
17 jam yang lalu
Treace Medical Concepts Inc (TMCI) Q3 2026 Earnings Call Highlig
Yahoo Finance
·
20 jam yang lalu
What Treace Medical Concepts (TMCI) Said on Its Q3 Earnings Call
Benzinga
·
1 hari yang lalu
Treace Medical Concepts Q3 2026 Earnings Call Transcript
Profil
Treace Medical Concepts, Inc. is a medical device company, headquartered in Ponte Vedra Beach, Florida, specializing in the design, manufacture, and marketing of foot and ankle surgical devices and biologics. Lapiplasty, Treace’s novel primary surgical product, advanced the treatment of bunions, surgically correcting the metatarsal bone, for the first time, in all three dimensions.
In March 2021, Treace announced its intent to launch an initial public offering. Trading on the Nasdaq under the ticker symbol “TMCI”, Treace opened its IPO in April 2021. Wikipedia
Tentang Treace Medical Concepts, Inc